Product Information
MESALAMINE DR 1.2 GM TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.8138 per EA under NDC 00591224522. Its NADAC has been published 420 times since Jun 13, 2018.
Strength
1.2 g/1
Manufacturer
Actavis Pharma, Inc.NDC
00591224522
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA203817On Market Since
3/26/2018
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE DR 1.2 GM TABLET has been published 420 times since Jun 13, 2018, and over the history we have for it it has declined 88.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8138 per EA |
|---|---|
| All-time high | $6.7753 (Jun 13, 2018) |
| All-time low | $0.8138 (Jun 17, 2026) |
| 52-week high | $1.1318 |
| 52-week low | $0.8138 |
| Median price | $2.6347 |
| Average price | $2.6599 |
| Largest weekly change | +45.9% (Aug 21, 2024) |
| Weeks tracked | 420 |
| Tracking since | Jun 13, 2018 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MESALAMINE DR 1.2 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE DR 1.2 GM TABLET, manufactured by Actavis Pharma, Inc., is $0.8138 per EA (NDC 00591224522), effective Jun 24, 2026.
How has the price of MESALAMINE DR 1.2 GM TABLET changed over time?
Over the history we have for it, the NADAC for MESALAMINE DR 1.2 GM TABLET has declined 88.0%. It has been tracked across 420 weekly CMS publications since Jun 13, 2018.
What are the highest and lowest recorded NADAC prices for MESALAMINE DR 1.2 GM TABLET?
Since Jun 13, 2018, the NADAC for MESALAMINE DR 1.2 GM TABLET has ranged from a low of $0.8138 (Jun 17, 2026) to a high of $6.7753 (Jun 13, 2018), with a median of $2.6347 per EA.
Are there cheaper alternatives to MESALAMINE DR 1.2 GM TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as MESALAMINE DR 1.2 GM TABLET, but none are currently priced below it.
Who manufactures MESALAMINE DR 1.2 GM TABLET?
MESALAMINE DR 1.2 GM TABLET (NDC 00591224522) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification